• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Should we start getting worried?





Only take the Collegium job if you are unemployed. Its a version of Oxycontin but Oxycontin lost its patent and will be generic. Better have HTH data if you want managed care to play ball.
Or sell the Puffer from Avanir. Your husband better be a headache specialist to sell that one.
 




















that is not what my manager said. He said FDA meeting on Ventrella in June and he thinks expansion will happen 4th qtr or 1st qtr. 2017. It's not 100% off the table but they can't keep everyone hanging!